BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Lenz Therapeutics Inc.

Headquarters: San Diego, CA, United States
Year Founded: 2013
Status: Public
Industry Sector: HealthTechnology
CEO: Evert B. Schimmelpennink
Number Of Employees: 42
Enterprise Value: $406,620,567
PE Ratio: -6.06
Exchange/Ticker 1: NASDAQ:LENZ
Exchange/Ticker 2: N/A
Latest Market Cap: $795,444,672